Peptide Therapeutics Market Offers Lucrative Growth Opportunities Driven by Rising R&D Investment

 

Peptide Therapeutics Market
Peptide Therapeutics Market

Peptide therapeutics refer to short chains of amino acids that are used in the treatment of various diseases. They mimic the effects of endogenous hormones, antibodies and other molecules and offer high potency and target specificity. Peptides act as chemical messengers between cells and help in performing various functions in the body. Some key advantages of peptide drugs are their low toxicity, high selectivity and ability to pass biological barriers. The growing prevalence of chronic diseases such as cancer, diabetes and cardiovascular disorders is increasing the need for more effective and targeted therapies. Furthermore, increasing investments in peptide-based drug research is also providing impetus to market growth.

The Global Peptide Therapeutics Market is estimated to be valued at US$ 51133.71 Bn in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Peptide Therapeutics are IBM Corporation, SAP SE, Oracle Corporation, ABB Ltd., Infor, Inc., Ultimo Software Solutions BV, CARL International SA, eMaint Enterprises, LLC, Mainsaver, Inc., MEX Pty Ltd., Asset Works LLC, and CGI, Inc. Major players are investing heavily in R&D to develop novel peptide drugs for chronic conditions with high unmet need. Meanwhile, strategic collaborations between Peptide Therapeutics Market Trends developers and drug delivery technology providers are opening up opportunities for improved efficacy and new product launches.

Geographically, North America dominated the global peptide therapeutics market in 2019. However, Asia Pacific is anticipated to witness the fastest growth rate over the forecast period driven by rising healthcare expenditures, growing elderly population and increasing focus of international players towards emerging Asian markets.

Market Drivers

Increasing prevalence of chronic diseases worldwide: The steady rise in the incidence of diseases such as cancer, diabetes and cardiovascular ailments is a key factor propelling the demand for more targeted and effective therapeutics including peptide drugs.

Favorable research funding for peptide drug development: Government and private organizations are increasing financing for research activities focused on exploring the therapeutic potential of bioactive peptides. Growing R&D investments are expected to lead to commercialization of novel peptide-based drugs over the coming years.

Market Restraints

High development costs: Significant expenditures are required from target identification and lead optimization to preclinical and clinical testing for a new peptide-based drug. This increases the overall costs associated with peptide drug development.

Manufacturing complexities: Production of therapeutic peptides is a complex multi-step process involving solid-phase peptide synthesis, extraction and purification. Ensuring consistent quality and scale-up can be challenging from a manufacturing perspective.

Segment Analysis

The Peptide Therapeutics Market can be segmented by type into Branded Peptide and Generic Peptide. Branded peptide currently dominates the market and holds around 65% share owing to the fact that most blockbuster peptide drugs are still under patent protection which prevents the entry of generic versions. Examples of some top selling branded peptide drugs are Liraglutide, Exenatide, Teduglutide etc.

Global Analysis

Regionally, North America currently leads the global Peptide Therapeutics Market with around 40% share. The presence of major pharmaceutical companies conducting peptide research and strong healthcare infrastructure are major factors for its domination. However, Asia Pacific is emerging as the fastest growing regional market growing at a CAGR of over 10% during the forecast period. Factors such as rising healthcare spending, growing geriatric population, increasing incidence of chronic diseases like cancer and diabetes are driving the growth of the peptide therapeutics market in Asia Pacific region. Countries like China and India offer huge untapped potential for peptide drugs market and are expected to contribute significantly to the global market growth in coming years.

Gets More Insights on, Peptide Therapeutics Market


About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)

Comments

Post a Comment

Popular posts from this blog

Lactate Meters Market is Anticipated to Witness High Growth Owing to Rising Incidences of Sports Injuries

Image
  Lactate Meters Market The lactate meters market has been gaining increasing prominence over the recent past owing to the rising incidences of sports injuries and training programs involving monitoring of lactate levels. Lactate meters help in measuring the amount of lactic acid present in the bloodstream which accumulates during intense physical activity. They play a pivotal role in sports medicine for athletes, coaches and health professionals to determine the level of exertion, evaluate fitness, track progress during training, monitor recovery and help prevent overtraining. They provide critical insights to plan personalized training programs and exercise regimes for athletes belonging to different sports such as soccer, rugby, swimming etc. The increasing focus on fitness among individuals has also augmented the demand for home-use lactate meters. The Global lactate meters market is estimated to be valued at US$ 296.8 Mn in 2024 and is expected to exhibit a CAGR of 8.8% over...
Read more

Blood Glucose Test Strip Market is Poised to Witness High Growth Due to Increasing Diabetes Prevalence

Image
Blood Glucose Test Strip Market Blood glucose test strips are thin, plastic strips that are used in handheld devices called glucometers to measure the concentration of glucose in the blood. Glucose levels are usually measured to monitor diabetes or check for hypoglycemia. Blood glucose test strips enable diabetics to effectively manage their blood glucose levels and determine insulin requirements. The increasing prevalence of diabetes across the globe is a major factor fueling the demand for blood glucose test strips. The Global Blood Glucose Test Strip Market is estimated to be valued at US$ 12.33 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 To 2031. Diabetes is a metabolic disorder in which the body is unable to produce enough insulin or properly use the insulin it produces, resulting in elevated levels of glucose in the blood. According to the International Diabetes Federation (IDF), around 537 million adults aged 20–79 years suffered from...
Read more

Next Generation Sequencing Market to Soar with Rising Personalized Medicine Demand

Image
  Next Generation Sequencing Market Next generation sequencing (NGS), also referred to as high throughput sequencing, refers to the new sequencing technologies including sequencing-by-synthesis, real-time sequencing, and sequencing-by-ligation. This technology allows DNA and RNA to be sequenced massively in parallel. NGS technology has revolutionized genomics research and enabled the sequencing of complete genomes more quickly and cost-effectively in comparison to traditional Sanger sequencing. NGS finds wide applications in various fields including oncology, reproductive health, pharmacogenetics, metabolic disorders diagnosis testing, agriculture, and microbiology research. The global next generation sequencing market is estimated to be valued at US$ 678.13 Mn in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the next generation sequencing market are Canopy Growth Corporation, Aurora Cannabis, Til...
Read more